Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Health Economic Impact and Highlighted Clinical/Safety Outcomes in 300 Relapsing Multiple Sclerosis Patients Treated with Alemtuzumab in a Single MS Center